Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biophan Technologies, Inc.
Data demonstrate success of solutions to improve MRI of Vena Cava filters
June 15th, 2005
Biophan Technologies, Inc., (BIPH), a developer of next-generation medical technology, has announced that a new round of experimental tests have demonstrated the ability of the company's proprietary technology to enable Magnetic Resonance Imaging (MRI) of Vena Cava filters. Vena Cava filters are implanted in the Vena Cava of some patients undergoing surgery to capture and trap blood clots that have the potential to cause embolisms. These mobile blood clots are one of the most common potentially fatal complications for patients undergoing surgery. Vena Cava filters are implanted in the inferior Vena Cava, a large vein that carries blood to the heart,...
Source: Physician Law Weekly (2005-06-15)
|
